Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome
Case Reports in Rheumatology · 24.05.2021 · 2021 · 1-3
DOI: 10.1155/2021/9323141 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Rheumatology, erschienen am 24.05.2021. Verfasst von Nicole Davidson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Residency Program, Nationwide Children's Hospital, Columbus, OH, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Systemic juvenile idiopathic arthritis (sJIA) is characterized by arthritis, fever, rash, lymphadenopathy, hepatosplenomegaly, and serositis. Macrophage activation syndrome is the most feared complication of sJIA with a high risk of mortality. We report a 16-year-old female diagnosed with refractory systemic juvenile idiopathic arthritis (sJIA) complicated by recurrent macrophage activation syndrome (MAS), severe joint disease, and lung involvement requiring prolonged immunosuppressive therapy. She received a matched unrelated allogeneic hematopoietic cell transplant (Allo-HCT) using a reduced-intensity conditioning regimen and is now, 3 years after the transplant, with complete resolution of sJIA symptoms, off immunosuppressants, and with significant improvement in the quality of life.
Autor:innen und Institutionen
- Pediatric Residency Program, Nationwide Children's Hospital, Columbus, OH, USA.
- Pediatric Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital, Columbus, OH, USA.
- Department of Pediatrics, The Ohio State University, OH, USA.
- Pediatric Rheumatology, Nationwide Children's Hospital, Columbus, OH, USA.
ORCID-Profile: Rolla F Abu-Arja
Zitieren
APA
Davidson, N., Rangarajan, H. G., Driest, K., Bajwa, R. P. S., Polishchuk, V., & Abu-Arja, R. F. (2021). Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Reports in Rheumatology, 2021, 1-3. https://doi.org/10.1155/2021/9323141
Vancouver
Davidson N, Rangarajan HG, Driest K, Bajwa RPS, Polishchuk V, Abu-Arja RF. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Case Reports in Rheumatology. 2021;2021:1-3. doi:10.1155/2021/9323141
BibTeX
@article{Davidson2021,
author = {Davidson, Nicole and Rangarajan, Hemalatha G and Driest, Kyla and Bajwa, Rajinder P S and Polishchuk, Veronika and Abu-Arja, Rolla F},
title = {Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome},
journal = {Case Reports in Rheumatology},
year = {2021},
volume = {2021},
pages = {1--3},
doi = {10.1155/2021/9323141}
}
EUVIMED